Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer.
about
Neoadjuvant nab-paclitaxel in the treatment of breast cancerA structured review of health utility measures and elicitation in advanced/metastatic breast cancerTargeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer.Comparing medical cost of care for patients with metastatic breast cancer receiving taxane therapy: claims analysis.Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective.nab-Paclitaxel dose and schedule in breast cancerCost-utility analyses of drug therapies in breast cancer: a systematic review.Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia.Review on early technology assessments of nanotechnologies in oncology.Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis.Receptor-targeted nanocarriers for therapeutic delivery to cancer.Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?Economic and societal dimensions of nanotechnology-enabled drug delivery.Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials.Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain.Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective.
P2860
Q26748822-03F5DC53-C0B0-4AD5-A323-6D0642EA2FD1Q28067255-2A73248C-0D8B-4BF3-A96B-282543A8066FQ33916040-AE2920A7-9D3B-4ACF-B462-6E7C4A471180Q33932401-59A30A65-4F1A-4DE6-9C30-43B90ABBB51BQ35617654-B5652AA3-227E-4F0C-B5D6-2A14A9B97B3AQ35734193-6B058F61-8068-4926-9A51-832987C31CC1Q36116276-1ACD3162-57B9-4923-85C8-20331D745C09Q36738535-E364447F-38F2-4122-986A-B9E10B9E6432Q37525371-524E5897-5BE6-48D0-92B0-E182EDD0A676Q37725620-24C265D4-6C0B-474A-9FDE-0441BD7BD587Q37804383-50DACF00-52A5-4F6A-A016-BF2CD96808FDQ37928232-7B29CBB9-21BB-4C30-A856-866D0548737FQ38081220-D0C139F5-16A9-4CBB-8576-6555990F9261Q42700716-65C3BD2E-1535-42EE-8F68-0A6B7FE36930Q43406910-F24A107A-509A-4365-AA9C-9A9C9F046356Q46192631-83F32113-9532-4AA8-8E54-B4E1D7340D2E
P2860
Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@en
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@nl
type
label
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@en
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@nl
prefLabel
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@en
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@nl
P2093
P2860
P356
P1476
Economic analysis of albumin-b ...... t of metastatic breast cancer.
@en
P2093
Biljana Spirovski
George Dranitsaris
Sean Hopkins
Wayne Cottrell
P2860
P356
10.1177/1078155208098584
P577
2008-11-26T00:00:00Z